In a new study sponsored by Enzymotec at Rambam Medical Center in Israel, mice engineered to act as a model for human cardiovascular disease were fed either with canola-based MultOil or a regular canola oil for a period of three months.
MultOil, recently launched by Enzymotec, contains 25 per cent phytosterols and 15 per cent diglycerides (DAG). The source of oils or fats can be either vegetable or dairy, depending on the food application.
Professor M. Aviram, head of the Lipid Research Laboratory at the Technion Faculty of Medicine, said the results from the MultOil consumption show significant cardiovascular health benefits.
The scientists believe that MultOil promotes cardiovascular health by fighting three major risk factors for coronary heart diseases: it reduces total cholesterol and triglyceride levels, it acts as an antioxidant to reduce blood serum oxidation levels by 60 per cent and it also prevents the formation of foam cells that plug the arteries.
"This is the first nutraceutical that has proven to act through a triple defence mechanism," said Dr Ariel Katz, Enzymotec's CEO.
He added that the findings point to a favourable outcome from an ongoing human trial at the McGill University, Canada.
"Furthermore, we believe that MultOil could answer the needs of rapidly increasing diabetic, overweight and obese populations," said Katz.